25th May 2009

NovaBiotics attends BIO-2009

NovaBiotics attends BIO-2009 and has a very successful week in Atlanta.  As expected, lots of interest was shown by numerous parties in the Company’s lead, Novexatin^®, but also in the therapeutic pipeline and consumer-health care focused technology, Luminaderm^®. In addition to being kept very busy in ‘on-to-one-partnering’ in the business forum section, NovaBiotics was also delighted to be a part of the Scottish Development International-led delegation and was represented within their exhibition space.